EUVIMEDEUVIMED entdecken
Crossref

Molecular Profile of Mucopolysaccharidosis Type I Patients in Brazil

Carlos Robson Costa Cruz, Edina Poletto iD, Larissa Mota Silva, Gabriela Pasqualim iD, Alice Brinckmann Oliveira Netto, Sandra Leistner, Ana Carolina Brusius-Facchin, Franciele Barbosa Trapp, Ursula Matte, Roberto Giugliani, Guilherme Baldo

Journal of Inherited Metabolic Disease · 2026

DOI: 10.1002/jimd.70144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2026. Verfasst von Carlos Robson Costa Cruz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cell, Tissue and Gene Laboratory, Experimental Research Center-Hospital de Clinicas de Porto Alegre (CTG/CPE-HCPA), Porto Alegre, RS, Brazil. Hauptthemen laut MEDLINE: Mucopolysaccharidosis I, Iduronidase. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucopolysaccharidosis type I (MPS I) is an autosomal recessive disease caused by mutations in the IDUA gene, resulting in decreased activity of the lysosomal enzyme α‐ l ‐iduronidase (IDUA) and consequent accumulation of glycosaminoglycans in the lysosomes. There are more than 300 disease‐causing variants reported in the IDUA gene, and the mutational profile varies considerably worldwide. In this study, we performed molecular analysis on 119 MPS I patients, representing the largest Brazilian cohort studied so far. Forty‐seven different mutations were identified in our sample, and 13 of them are newly described: c.48delG, c.78delC, c.159‐23_159‐1del23, p.Gln125Ter, p.Trp175Ter, c.590‐6ins4G, c.763delC, c.973‐1G>A, p.Asp349Glu, p.Asn350Lys, p.Lys384Asn, c.1403‐12_1403‐4del9, and p.Lys546Ter. In silico analysis of novel variants suggests they are possibly pathogenic, supporting previous biochemical and clinical diagnoses. Among recurrent mutations, p.Trp402Ter and p.Pro533Arg are the most frequent in Brazil, found in 42.4% and 16% of the alleles, respectively. These results reveal the great allelic heterogeneity of IDUA variants in Brazilian patients. Unraveling the genetic profile of MPS I patients may improve the diagnosis and management of this rare disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucopolysaccharidosis IIduronidaseHumansBrazilMutationFemaleChild, PreschoolChildMaleInfantDNA Mutational AnalysisGlycosaminoglycansAdolescent

Stichwörter der Autor:innen

IDUAScheie syndromealfa‐l‐iduronidasehurler syndromelysosomal diseasemolecular analysismucopolysaccharidosis type Imutation profilepathogenic variants

Substanzen

IduronidaseIDUA protein, humanGlycosaminoglycans

Autor:innen und Institutionen

  • Cell, Tissue and Gene Laboratory, Experimental Research Center-Hospital de Clinicas de Porto Alegre (CTG/CPE-HCPA), Porto Alegre, RS, Brazil.
  • Postgraduate Program in Genetics and Molecular Biology, Federal University of Rio Grande Do Sul (PPGBM/UFRGS), Porto Alegre, RS, Brazil.
  • Genetics Laboratory, Institute of Biological Sciences, Federal University of Rio Grande (FURG), Rio Grande, Brazil.
  • Postgraduate Program in Health Sciences (PPGCS), Federal University of Rio Grande (FURG), Porto Alegre, RS, Brazil.
  • Medical Genetics Service, Hospital de Clinicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
  • Instituto Genética Para Todos (IGPT), Porto Alegre, RS, Brazil.

ORCID-Profile: Edina Poletto, Gabriela Pasqualim

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS)
  • Fundo de Incentivo à Pesquisa-Hospital de Clínicas de Porto Alegre (FIPE-HCPA)
  • Hospital de Clínicas de Porto Alegre

Zitieren

APA

Cruz, C. R. C., Poletto, E., Silva, L. M., Pasqualim, G., Netto, A. B. O., Leistner, S., Brusius-Facchin, A. C., Trapp, F. B., Matte, U., Giugliani, R., & Baldo, G. (2026). Molecular Profile of Mucopolysaccharidosis Type I Patients in Brazil. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70144

Vancouver

Cruz CRC, Poletto E, Silva LM, Pasqualim G, Netto ABO, Leistner S, et al. Molecular Profile of Mucopolysaccharidosis Type I Patients in Brazil. Journal of Inherited Metabolic Disease. 2026. doi:10.1002/jimd.70144

BibTeX
@article{Cruz2026,
  author = {Cruz, Carlos Robson Costa and Poletto, Edina and Silva, Larissa Mota and Pasqualim, Gabriela and Netto, Alice Brinckmann Oliveira and Leistner, Sandra and Brusius-Facchin, Ana Carolina and Trapp, Franciele Barbosa and Matte, Ursula and Giugliani, Roberto and Baldo, Guilherme},
  title = {Molecular Profile of Mucopolysaccharidosis Type I Patients in Brazil},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  doi = {10.1002/jimd.70144}
}
Kostenlos starten →